Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 12.5759.64-14.83-17.6213.02

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 12.57 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹60,711.0 Cr -0.1% -6.9% -30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,002.0 Cr -2.1% -5.8% -6.7% Stock Analytics
DIVIS LABORATORIES ₹164,334.0 Cr 3.1% -6.5% 28.7% Stock Analytics
CIPLA ₹127,613.0 Cr 2.2% 3.2% 1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,923.0 Cr -1.7% NA 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,437.0 Cr 1.4% -1.1% -7.6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.9%

-30.6%

SENSEX

-1.1%

-1.7%

-0.3%


You may also like the below Video Courses